Search

Author/Creator Yuen, S.

4. POLATUZUMAB VEDOTIN + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL. (17th June 2021)

Authors:
Bannerji, R.; Yuen, S.; Phillips, T.; Arthur, C.; Isufi, I.; Marlton, P.; Seymour, J. F.; Corradini, P.; Molinari, A.; Gritti, G.; Emmons, R.; Hirata, J.; Musick, L.; Saha, S.; Croft, B.; Flowers, C.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. S205: ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 2 RANDOMIZED ROSEWOOD TRIAL. (23rd June 2022)

Authors:
Zinzani, P. L.; Mayer, J.; Auer, R.; Bijou, F.; de Oliveira, A. C.; Flowers, C. R.; Merli, M.; Bouabdallah, K.; Ganly, P. S.; Song, Y.; Zhang, H.; Johnson, R.; García-Sancho, A. M; Provencio, M.; Trněný, M.; Yuen, S.; Tilly, H.; Kingsley, E.; Tuyman, G.; Assouline, S. E.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
106
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗